Nektar (NKTR) announced three oral presentations at EADV Congress 2026 for rezpegaldesleukin, including new 6-month off-treatment data from the REZOLVE-AA alopecia areata study. Investor call Oct 1 at 8 AM ET.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
